How were Senomyx's earnings last quarter?

Senomyx, Inc. (NASDAQ:SNMX) issued its quarterly earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01. The specialty chemicals company had revenue of $3.29 million for the quarter. Senomyx had a negative net margin of 9.11% and a negative trailing twelve-month return on equity of 15.80%.

What other stocks do shareholders of Senomyx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senomyx investors own include Aralez Pharmaceuticals (ARLZ) , Heron Therapeutics (HRTX) , Novavax (NVAX) , Rexahn Pharmaceuticals (REXN) , Vical (VICL) , (CASC) (CASC) , DURECT (DRRX) , Idera Pharmaceuticals (IDRA) , Inovio Pharmaceuticals (INO) and Lexicon Pharmaceuticals (LXRX) .

NASDAQ:SNMX

Senomyx (SNMX) Stock Price, News & Analysis

→ “Forget Tesla, this is Elon’s Next Big Thing” (From InvestorPlace) (Ad)

Free SNMX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $1.49
▼
$1.49
50-Day Range: N/A
52-Week Range: $0.83
▼
$1.71

Volume: N/A
Average Volume: 151,720 shs
Market Capitalization: $72.03 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Senomyx alerts:

Ad Gold Safe Exchange

Trump’s “Tax Free” Retirement Strategy

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…

About Senomyx Stock (NASDAQ:SNMX)

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

Ad Gold Safe Exchange

Trump’s “Tax Free” Retirement Strategy

Protect your retirement savings from the inevitable devaluation of the dollar…

SNMX Stock News Headlines

December 9, 2023 | morningstar.com

AKD Securities Ltd Ordinary Shares AKDSL

July 19, 2023 | investing.com

NZ Automotive Investments Ltd (NZA)

April 16, 2024 | Crypto Swap Profits (Ad)

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

March 30, 2023 | thestreet.com

McKesson Inc. (MCK): Today's Featured Wholesale Laggard

February 23, 2023 | usatoday.com

Fact check: Fetal tissue not in your food, drinks, experts say

June 2, 2022 | thestreet.com

How to Get Stock Exposure to Gluten-Free Movement

January 29, 2022 | fool.com

Senomyx, Inc.(SNMX)

See More Headlines

Receive SNMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senomyx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/02/2018
Today: 4/16/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Consumer Staples
Industry: Commercial Physical Research
Sub-Industry: N/A
Current Symbol: NASDAQ:SNMX
CUSIP: N/A
CIK: 1123979
Web: www.senomyx.com
Phone: 858-646-8300
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.03)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-1,260,000.00
Net Margins: -9.11%
Pretax Margin: N/A
Return on Equity: -15.80%
Return on Assets: -10.48%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.35
Quick Ratio: 3.92

Sales & Book Value

Annual Sales: $29.32 million
Price / Sales: 2.46
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.39 per share
Price / Book: 3.82

Miscellaneous

Outstanding Shares: 48,340,000
Free Float: N/A
Market Cap: $72.03 million
Optionable: Optionable
Beta: 1.33

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. John W. Poyhonen (Age 58)
Pres, CEO & Director
Mr. David C. Humphrey (Age 49)
VP & CFO
Ms. Catherine C. Lee (Age 44)
Sr. VP, Gen. Counsel & Corp. Sec.
Ms. Sharon Wicker (Age 62)
Sr. VP & Chief Commercial Devel. Officer
Ms. Susan Firestone Melody
VP of HR

Key Competitors

View All Competitors

SNMX Stock Analysis - Frequently Asked Questions

How were Senomyx's earnings last quarter?: Senomyx, Inc. (NASDAQ:SNMX) issued its quarterly earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01. The specialty chemicals company had revenue of $3.29 million for the quarter. Senomyx had a negative net margin of 9.11% and a negative trailing twelve-month return on equity of 15.80%.
What other stocks do shareholders of Senomyx own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC), DURECT (DRRX), Idera Pharmaceuticals (IDRA), Inovio Pharmaceuticals (INO) and Lexicon Pharmaceuticals (LXRX).

This page (NASDAQ:SNMX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Senomyx (SNMX) Stock Price, News & Analysis

About Senomyx Stock (NASDAQ:SNMX)

SNMX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SNMX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info